Company
Headquarters: Sydney, NSW, Australia
Founded: 1981
Employees: 4,000
CEO: Mr. Diggory William Howitt BE (Hons), MBA
A$19.57 Billion
AUD as of Jan. 1, 2024
US$13.33 Billion
Company | Market Cap (USD) |
---|---|
Abbott | $192.67 B |
Stryker Corporation | $113.24 B |
Medtronic | $111.60 B |
Boston Scientific Corporation | $85.22 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Cochlear Limited has the following listings and related stock indices.
Stock: ASX: COH wb_incandescent
Cochlear implantsBone-anchored hearing aidsCochlear wireless accessoriesBone anchored prosthetics
Dig Howitt (CEO) Rick Holliday- Smith (Chairman)
Revenue: A$1240 million (2017)
Net income: A$224 million (2017)